We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agennix Announces Issuance of European Patent Covering Use of Talactoferrin to Treat Cancer

News   Aug 12, 2011

 
Agennix Announces Issuance of European Patent Covering Use of Talactoferrin to Treat Cancer
 
 
 

RELATED ARTICLES

Whole Genome Sequencing for Personalized Antibiotic Therapy

News

Researchers have added to evidence that rapid resistance gene sequencing technology can accurately speed the identification of specific antibiotic-resistant bacteria strains that sicken and kill some patients.

READ MORE

Another Piece of Ebola Virus Puzzle

News

Researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

READ MORE

Specific Obesity-related Risk Factors for Kidney Cancer

News

A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma (RCC), a type of kidney cancer, and identifies several specific obesity-related factors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE